Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Free Cash Flow: 2010-2025

Historic Free Cash Flow for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$15.7 million.

  • SRx Health Solutions' Free Cash Flow fell 44647.69% to -$15.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$15.4 million, marking a year-over-year decrease of 20007.81%. This contributed to the annual value of $79000.0 for FY2023, which is 10038.07% up from last year.
  • SRx Health Solutions' Free Cash Flow amounted to -$15.7 million in Q2 2025, which was down 44647.69% from $377000.0 recorded in Q1 2025.
  • SRx Health Solutions' 5-year Free Cash Flow high stood at $983000.0 for Q4 2023, and its period low was -$15.7 million during Q2 2025.
  • Moreover, its 5-year median value for Free Cash Flow was -$2.4 million (2021), whereas its average is -$3.2 million.
  • Per our database at Business Quant, SRx Health Solutions' Free Cash Flow skyrocketed by 13808.6% in 2023 and then crashed by 132076.27% in 2024.
  • SRx Health Solutions' Free Cash Flow (Quarter) stood at -$3.8 million in 2021, then surged by 31.48% to -$2.6 million in 2022, then skyrocketed by 138.09% to $983000.0 in 2023, then tumbled by 325.23% to -$2.2 million in 2024, then plummeted by 611.11% to -$15.7 million in 2025.
  • Its Free Cash Flow stands at -$15.7 million for Q2 2025, versus $377000.0 for Q1 2025 and -$2.2 million for Q3 2024.